Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Parecoxib
Product Details | |
---|---|
Synonyms | N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide; Dynastat; SC-69124 |
Product Type | Chemical |
Properties | |
Formula | C19H18N2O4S |
MW | 370.4 |
CAS | 198470-84-7 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥98% (HPLC) |
Appearance | White powder. |
Solubility | Soluble in water. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by Chemodex. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | TZRHLKRLEZJVIJ-UHFFFAOYSA-N |
Smiles | O=C(CC)NS(=O)(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Potent and selective COX-2 inhibitor. Water-soluble amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib. Has anti-inflammatory, analgesic, and antipyretic activities. Upon administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib.
(1) J.J. Talley, et al.; J. Med. Chem. 43, 1661 (2000) | (2) S.S. Padi, et al.; Eur. J. Pharmacol. 491, 69 (2004) | (3) A.B. Reksidler, et al.; Eur. J. Pharmacol. 560, 163 (2007) | (4) A. Abbate, et al.; J. Cardiovasc. Pharmacol. 49, 416 (2007) | (5) H. Schroeder, et al.; Neurochem. Int. 58, 9 (2011) | (6) Z. Ye, et al.; Neurochem. Res. 37, 321 (2012) | (7) S.J.Chong, et al.; Int. J. Inflam. 2014, 972645 (2014)